Lynch Ryan

Track

Insider profile

Lynch Ryan's trades of Crescent Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
123.85
Quantity 34,264 +28.3%
Value US$2,270,395
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-22
PlS Planned sale
34,264 +28.3%
123.85
US$2,270,395 		34,264 +28.3% 123.85 US$2,270,395